298 related articles for article (PubMed ID: 26335433)
1. Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
Goupil R; Fountoulakis S; Gordon RD; Stowasser M
J Hypertens; 2015 Nov; 33(11):2286-93. PubMed ID: 26335433
[TBL] [Abstract][Full Text] [Related]
2. Overnight/first-morning urine free metanephrines and methoxytyramine for diagnosis of pheochromocytoma and paraganglioma: is this an option?
Peitzsch M; Kaden D; Pamporaki C; Langton K; Constantinescu G; Conrad C; Fliedner S; Sinnott RO; Prejbisz A; Därr R; Lenders JWM; Bursztyn M; Eisenhofer G
Eur J Endocrinol; 2020 May; 182(5):499-509. PubMed ID: 32187575
[TBL] [Abstract][Full Text] [Related]
3. Properly Collected Plasma Metanephrines Excludes PPGL After False-Positive Screening Tests.
Kline GA; Boyd J; Polzin B; Harvey A; Pasieka JL; Sadrzadeh HSM; Leung AA
J Clin Endocrinol Metab; 2021 Jul; 106(8):e2900-e2906. PubMed ID: 33846745
[TBL] [Abstract][Full Text] [Related]
4. Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
Tsiomidou S; Pamporaki C; Geroula A; Van Baal L; Weber F; Dralle H; Schmid KW; Führer D; Unger N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):541-550. PubMed ID: 35274752
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
Perry CG; Sawka AM; Singh R; Thabane L; Bajnarek J; Young WF
Clin Endocrinol (Oxf); 2007 May; 66(5):703-8. PubMed ID: 17388796
[TBL] [Abstract][Full Text] [Related]
6. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
7. Plasma metanephrines in the diagnosis of pheochromocytoma.
Lenders JW; Keiser HR; Goldstein DS; Willemsen JJ; Friberg P; Jacobs MC; Kloppenborg PW; Thien T; Eisenhofer G
Ann Intern Med; 1995 Jul; 123(2):101-9. PubMed ID: 7778821
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic Acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma.
Boyle JG; Davidson DF; Perry CG; Connell JM
J Clin Endocrinol Metab; 2007 Dec; 92(12):4602-8. PubMed ID: 17635948
[TBL] [Abstract][Full Text] [Related]
9. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
10. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.
Gardet V; Gatta B; Simonnet G; Tabarin A; Chêne G; Ducassou D; Corcuff JB
J Hypertens; 2001 Jun; 19(6):1029-35. PubMed ID: 11403350
[TBL] [Abstract][Full Text] [Related]
11. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
Peaston RT; Lennard TW; Lai LC
J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
[TBL] [Abstract][Full Text] [Related]
12. Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
Remde H; Pamporaki C; Quinkler M; Nölting S; Prejbisz A; Timmers HJLM; Masjkur J; Fuss CT; Fassnacht M; Eisenhofer G; Deutschbein T
Hypertension; 2022 Jun; 79(6):1257-1264. PubMed ID: 35378989
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis of pheochromocytoma and paraganglioma-induced secondary hypertension through UPLC-MS/MS analysis of plasma catecholamines and their metabolites.
Zhang W; Li X; Li W; Zhang Y; Cai J; Feng S; Sun Z
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):416-424. PubMed ID: 38459755
[TBL] [Abstract][Full Text] [Related]
14. Different diagnostic cut-off values of urinary fractionated metanephrines according to sex for the diagnosis of pheochromocytoma in Korean subjects.
Sohn SY; Park HD; Lee SY; Kim JH; Jung BC; Kim HJ; Jang HW; Kim KW; Lee MK; Min YK; Kim JH
Endocr J; 2012; 59(9):831-8. PubMed ID: 22785075
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of urinary metanephrines for the diagnosis of pheochromocytoma].
Bachali Belhadj A; Cherif Miladi E; Bahri S; Chaabane A; Lamouchi H; Khiari K; Khalfallah N; Ben Ammar S
Tunis Med; 2013 Dec; 91(12):724-8. PubMed ID: 24458676
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
Därr R; Lenders JW; Stange K; Kindel B; Hofbauer LC; Bornstein SR; Eisenhofer G
Dtsch Med Wochenschr; 2013 Jan; 138(3):76-81. PubMed ID: 23299341
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
18. A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.
Lee GR; Johnston PC; Atkinson AB; McKillop D; Auld P; Hunter SJ
J Hypertens; 2011 Dec; 29(12):2422-8. PubMed ID: 22002333
[TBL] [Abstract][Full Text] [Related]
19. The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements.
Mulinari RA; Zanella MT; Guerra EM; Kohlmann O; Saad CI; Andriollo A; Carvalho JG; Ribeiro AB
Braz J Med Biol Res; 1987; 20(1):43-6. PubMed ID: 3690046
[TBL] [Abstract][Full Text] [Related]
20. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
Sawka AM; Jaeschke R; Singh RJ; Young WF
J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
